Rapid Diagnostic Tests for Visceral Leishmaniasis Reviewed
By LabMedica International staff writers Posted on 30 Jun 2014 |
The effectiveness of rapid diagnostic tests (RDTs) in diagnosing patients with visceral leishmaniasis (VL) has been reviewed by an independent expert group.
VL is caused by a parasite and results in fever, a large spleen and other health problems and diagnosis is extremely important as without treatment it can be fatal and proper treatment can result in a cure.
Scientists from the Cochrane Infectious Disease Group, coordinated through the editorial base in Liverpool School of Tropical Medicine (UK) found 24 studies, which contained information about five different RDTs, with a total of 4,271 participants. They describe how accurate these rapid diagnostic tests are for diagnosing VL in people who, according to their physicians, could have the disease. Only studies in which the investigators had used established methods to distinguish the people with VL from those who did not have the disease were used in the review.
One RDT, the rK39 immunochromatographic test (ICT) gave correct, positive results in 92% of the people with VL and it gave correct, negative results in 92% of the people who did not have the disease. The test worked better in India and Nepal than in East Africa. In India and Nepal, it gave correct, positive results in 97% of the people with the disease. In East Africa, it gave correct, positive results in only 85% of the people with the disease.
In 11 of the studies, the InBios rK39 ICT test (Seattle WA, USA) was used; four studies assessed the DiaMed rK39 ICT test (Cressier, Switzerland) and three evaluated other tests. There were no significant differences in diagnostic accuracy between commercial brands. A second RDT, the latex agglutination test gave correct, positive results in 64% of the people with the disease and it gave correct, negative results in 93% of the people without the disease.
Marleen Boelaert, PhD, from Institute of Tropical Medicine (Antwerp, Belgium) and the senior author of the report, said, “The best chance of a cure for VL lies in a correct diagnosis, so utilizing accurate RDTs is of paramount importance. Our review indicates that the rK39 ICT shows higher sensitivity and specificity for the diagnosis of VL in patients with febrile splenomegaly and no previous history of the disease than the latex agglutination test, but the sensitivity is notably lower in East Africa than in the Indian subcontinent. The size of the studies involving the other RDTs lack accuracy, validation, or both.” The report was published on June 20, 2014, in the journal the Cochrane Library.
Related Links:
Liverpool School of Tropical Medicine
InBios
DiaMed
VL is caused by a parasite and results in fever, a large spleen and other health problems and diagnosis is extremely important as without treatment it can be fatal and proper treatment can result in a cure.
Scientists from the Cochrane Infectious Disease Group, coordinated through the editorial base in Liverpool School of Tropical Medicine (UK) found 24 studies, which contained information about five different RDTs, with a total of 4,271 participants. They describe how accurate these rapid diagnostic tests are for diagnosing VL in people who, according to their physicians, could have the disease. Only studies in which the investigators had used established methods to distinguish the people with VL from those who did not have the disease were used in the review.
One RDT, the rK39 immunochromatographic test (ICT) gave correct, positive results in 92% of the people with VL and it gave correct, negative results in 92% of the people who did not have the disease. The test worked better in India and Nepal than in East Africa. In India and Nepal, it gave correct, positive results in 97% of the people with the disease. In East Africa, it gave correct, positive results in only 85% of the people with the disease.
In 11 of the studies, the InBios rK39 ICT test (Seattle WA, USA) was used; four studies assessed the DiaMed rK39 ICT test (Cressier, Switzerland) and three evaluated other tests. There were no significant differences in diagnostic accuracy between commercial brands. A second RDT, the latex agglutination test gave correct, positive results in 64% of the people with the disease and it gave correct, negative results in 93% of the people without the disease.
Marleen Boelaert, PhD, from Institute of Tropical Medicine (Antwerp, Belgium) and the senior author of the report, said, “The best chance of a cure for VL lies in a correct diagnosis, so utilizing accurate RDTs is of paramount importance. Our review indicates that the rK39 ICT shows higher sensitivity and specificity for the diagnosis of VL in patients with febrile splenomegaly and no previous history of the disease than the latex agglutination test, but the sensitivity is notably lower in East Africa than in the Indian subcontinent. The size of the studies involving the other RDTs lack accuracy, validation, or both.” The report was published on June 20, 2014, in the journal the Cochrane Library.
Related Links:
Liverpool School of Tropical Medicine
InBios
DiaMed
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Microbiology News
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia